This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sato, Y. Articles by Satoh, K. Search for Related Content PubMed PubMed Citation Articles by Sato, Y. Articles by Satoh, K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Hip Injuries and Disorders Hip Replacement Nutrition Stroke Hazardous Substances DB PARATHYROID HORMONE Related Collections Other Stroke Treatment - Medical Primary and Secondary Stroke Prevention Rehabilitation, Stroke

(Stroke. 2001;32:1673.)
© 2001 American Heart Association, Inc.

Original Contributions

Vitamin D Deficiency and Risk of Hip Fractures Among Disabled Elderly Stroke Patients

Yoshihiro Sato, MD; Takeshi Asoh, MD; Izumi Kondo, MD Kei Satoh, MD

From the Department of Neurology, Kurume University Medical Center (Y.S.); Department of Internal Medicine, Futase Social Insurance Hospital, Iizuka (T.A.); and Departments of Rehabilitation Medicine (Y.S., I.K.) and Vascular Biology (K.S.), Institute of Brain Science, Hirosaki University School of Medicine (Japan).

Correspondence to Dr Yoshihiro Sato, Department of Rehabilitation Medicine, Institute of Brain Science, Hirosaki University School of Medicine, 5 Zaifu-cho, Hirosaki 036-8562, Japan. E-mail noukenrs{at}cc.hirosaki-u.ac.jp

Background and Purpose—Risk of hip fracture after stroke is 2 to 4 times that in a reference population. Osteomalacia is present in some patients with hip fractures in the absence of stroke, while disabled elderly stroke patients occasionally have severe deficiency in serum concentrations of 25-hydroxyvitamin D (25-OHD) (5 ng/mL). To determine the effects of vitamin D status on hip fracture risk, we prospectively studied a cohort of patients with hemiplegia after stroke who were aged at least 65 years.

Methods—We compared baseline serum indices of bone metabolism, bone mineral density, and hip fracture occurrence in stroke patients with serum 25-OHD 25 nmol/L (10 ng/mL; deficient group, n=88) with findings in patients from the same cohort who had 25-OHD levels 26 to 50 nmol/L (10 to 20 ng/mL; insufficient group, n=76) or 51 nmol/L (21 ng/mL; sufficient group, n=72).

Results—Over a 2-year follow-up interval, hip fractures on the paretic side occurred in 7 patients in the deficient group and 1 patient in the insufficient group (P<0.05; hazard ratio=6.5), while no hip fractures occurred in the sufficient group. The 7 hip fracture patients in the deficient group had an osteomalacic 25-OHD level of <5 ng/mL. Higher age and severe immobilization were noted in the deficient group. Serum 25-OHD levels correlated positively with age, Barthel Index, and serum parathyroid hormone.

Conclusions—Elderly disabled stroke patients with serum 25-OHD concentrations 12 nmol/L (5 ng/mL) have an increased risk of hip fracture. Immobilization and advanced age cause severe 25-OHD deficiency and consequent reduction of BMD.

Key Words: bone diseases • elderly • hemiplegia • osteoporosis

This article has been cited by other articles:

				J. Marsden, L. M. Gibson, C. E. Lightbody, A. K. Sharma, M. Siddiqi, and C. Watkins Can early onset bone loss be effectively managed in post-stroke patients? An integrative review of the evidence Age Ageing, March 1, 2008; 37(2): 142 - 150. [Abstract] [Full Text] [PDF]

				Y. Sato, T. Kanoko, K. Satoh, and J. Iwamoto Prevention of Hip Fracture in Elderly Women With Alzheimer Disease--Reply Arch Intern Med, May 22, 2006; 166(10): 1145 - 1145. [Full Text] [PDF]

				Y. Sato, J. Iwamoto, T. Kanoko, and K. Satoh Risedronate Sodium Therapy for Prevention of Hip Fracture in Men 65 Years or Older After Stroke Arch Intern Med, August 8, 2005; 165(15): 1743 - 1748. [Abstract] [Full Text] [PDF]

				Y. Sato, Y. Honda, J. Iwamoto, T. Kanoko, and K. Satoh Effect of Folate and Mecobalamin on Hip Fractures in Patients With Stroke: A Randomized Controlled Trial JAMA, March 2, 2005; 293(9): 1082 - 1088. [Abstract] [Full Text] [PDF]

				Y. Sato, N. Metoki, J. Iwamoto, and K. Satoh Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in stroke patients Neurology, August 12, 2003; 61(3): 338 - 342. [Abstract] [Full Text] [PDF]